Twist Bioscience Corp (TWST): Depreciation & Amortization
$24.85M
Year ended 2025-09-30
$25.39M
Trailing 12 months to 2026-06-30
+14.6%
3-year compound annual growth
+30.1%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $24.85M | -20.9% | 2025-11-17, From 2024-10-01 |
| 2024-09-30 | $31.43M | +7.2% | 2025-11-17, From 2023-10-01 |
| 2023-09-30 | $29.31M | +77.5% | 2025-11-17, From 2022-10-01 |
| 2022-09-30 | $16.51M | +69.4% | 2024-11-18, From 2021-10-01 |
| 2021-09-30 | $9.75M | +46.0% | 2023-11-21, From 2020-10-01 |
| 2020-09-30 | $6.68M | +9.3% | 2023-06-05, From 2019-10-01 |
| 2019-09-30 | $6.11M | +6.7% | 2021-11-23, From 2018-10-01 |
| 2018-09-30 | $5.73M | +14.1% | 2020-11-27, From 2017-10-01 |
| 2017-09-30 | $5.02M | n/a | 2019-12-13, From 2016-10-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | 2025-09-30 | $24.85M | -20.9% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $3.10M | -26.2% |
| ADMA Biologics, Inc. (ADMA) | 2025-12-31 | $8.10M | +0.6% |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | $16.00M | -8.3% |
| Vericel Corp (VCEL) | 2025-12-31 | $11.54M | +109.7% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $35.94M | -4.4% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $8.58M | -3.1% |
| Repligen Corp (RGEN) | 2025-12-31 | $78.75M | +13.0% |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $15.62M | -3.7% |
Compare TWST, IMCR, ADMA, ADPT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗